Capasso M, Franceschi M, Rodriguez-Castro KI, Crafa P, Cambiè G, Miraglia C, et al. Epidemiology and risk factors of pancreatic cancer. Acta BioMed. 2018;89:141–6.
Martens S, Lefesvre P, Nicolle R, Biankin AV, Puleo F, Van Laethem JL, et al. Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications. Ann Oncol. 2019;30(9):1428–36.
CAS PubMed Article Google Scholar
Schlitter AM, Segler A, Steiger K, Michalski CW, Jäger C, Konukiewitz B, et al. Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): identification of prognostic subtypes. Sci Rep. 2017;1(7):41064.
Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am. 2011;40(1):1–18.
Rindi G, Wiedenmann B. Neuroendocrine neoplasms of the gut and pancreas: new insights. Nat Rev Endocrinol. 2011;8(1):54–64.
PubMed Article CAS Google Scholar
Păun I, Becheanu G, Costin AI, Constantin VD, Mihai GM, Radu L, et al. Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system: a review. Rom J Morphol Embryol. 2018;59(3):673–8.
Watanabe I, Sasaki S, Konishi M, Nakagohri T, Inoue K, Oda T, et al. Onset symptoms and tumor locations as prognostic factors of pancreatic cancer. Pancreas. 2004;28(2):160–5.
Mills K, Birt L, Emery JD, Hall N, Banks J, Johnson M, et al. Understanding symptom appraisal and help-seeking in people with symptoms suggestive of pancreatic cancer: a qualitative study. BMJ Open. 2017;7(9): e015682.
PubMed PubMed Central Article Google Scholar
McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24(43):4846–61.
PubMed PubMed Central Article Google Scholar
Garcia-Carbonero R, Sorbye H, Baudin E, Raymond E, Wiedenmann B, Niederle B, et al. ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas. Neuroendocrinology. 2016;103(2):186–94.
CAS PubMed Article Google Scholar
Yao W-Q, Wu X, Li G-D, Wu W-L, Wang W-Y. ACTH-secreting pancreatic neuroendocrine carcinoma with ovarian and pelvic metastases causing cushing’s syndrome: a case report. Int J Clin Exp Pathol. 2015;8(11):15396–401.
PubMed PubMed Central Google Scholar
Pescatori LC, Festa S, Panzuto F, Pilozzi E, Prosperi D, Rinzivillo M, et al. A case of pancreatic small cell neuroendocrine carcinoma associated with SIADH. Pancreas. 2016;45(5):e20-22.
Ren B, Liu X, Suriawinata AA. Pancreatic ductal adenocarcinoma and its precursor lesions: histopathology, cytopathology, and molecular pathology. Am J Pathol. 2019;189(1):9–21.
Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182–8.
Patlas M, Deitel W, Taylor B, Gallinger S, Wilson SR. Focal chronic pancreatitis mimicking pancreatic head carcinoma: are there suggestive features on ultrasound? Can Assoc Radiol J. 2007;58(1):15–21.
Zhang S, Defrias DVS, Alasadi R, Nayar R. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA): experience of an academic centre in the USA. Cytopathology. 2010;21(1):35–43.
CAS PubMed Article Google Scholar
Lee ES, Lee JM. Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol. 2014;20(24):7864–77.
PubMed PubMed Central Article Google Scholar
Wartski M, Sauvanet A. 18F-FDG PET/CT in pancreatic adenocarcinoma: a role at initial imaging staging? Diagn Interv Imaging. 2019;100(12):735–41.
CAS PubMed Article Google Scholar
Wang Z, Chen J-Q, Liu J-L, Qin X-G, Huang Y. FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis. World J Gastroenterol. 2013;19(29):4808–17.
PubMed PubMed Central Article Google Scholar
Duffy MJ, Sturgeon C, Lamerz R, Haglund C, Holubec VL, Klapdor R, et al. Tumor markers in pancreatic cancer: a European group on tumor markers (EGTM) status report. Ann Oncol. 2010;21(3):441–7.
CAS PubMed Article Google Scholar
Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19–9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007;33(3):266–70.
CAS PubMed Article Google Scholar
Humphris JL, Chang DK, Johns AL, Scarlett CJ, Pajic M, Jones MD, et al. The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Ann Oncol. 2012;23(7):1713–22.
CAS PubMed PubMed Central Article Google Scholar
Lee DW, Kim MK, Kim HG. Diagnosis of pancreatic neuroendocrine tumors. Clin Endosc. 2017;50(6):537–45.
PubMed PubMed Central Article Google Scholar
Kim JH, Eun HW, Kim YJ, Lee JM, Han JK, Choi B-I. Pancreatic neuroendocrine tumour (PNET): staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma. Eur Radiol. 2016;26(5):1338–47.
Lee L, Ito T, Jensen RT. Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies. Expert Rev Anticancer Ther. 2018;18(9):837–60.
CAS PubMed PubMed Central Article Google Scholar
Li J, Lin JP, Shi LH, Wang WJ, Li AQ, Si JM, et al. How reliable is the Ki-67 cytological index in grading pancreatic neuroendocrine tumors? a meta-analysis. J Dig Dis. 2016;17(2):95–103.
CAS PubMed Article Google Scholar
Jeon SK, Lee JM, Joo I, Lee ES, Park HJ, Jang J-Y, et al. Nonhypervascular pancreatic neuroendocrine tumors: differential diagnosis from pancreatic ductal adenocarcinomas at MR imaging-retrospective cross-sectional study. Radiology. 2017;284(1):77–87.
Binderup T, Knigge U, Loft A, Federspiel B, Kjaer A. 18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors. Clin Cancer Res. 2010;16(3):978–85.
CAS PubMed Article Google Scholar
Korse CM, Taal BG, Vincent A, van Velthuysen M-LF, Baas P, Buning-Kager JCGM, et al. Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade A. marker study of chromogranin A, neuron specific enolase, progastrin-releasing peptide and cytokeratin fragments. Eur J Cancer. 2012;48(5):662–71.
CAS PubMed Article Google Scholar
Strosberg JR, Halfdanarson TR, Bellizzi AM, Chan JA, Dillon JS, Heaney AP, et al. The north American neuroendocrine tumor society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors. Pancreas. 2017;46(6):707–14.
PubMed PubMed Central Article Google Scholar
Jain R, Fischer S, Serra S, Chetty R. The use of cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver. Appl Immunohistochem Mol Morphol. 2010;18(1):9–15.
CAS PubMed Article Google Scholar
Vilá MR, Balagué C, Real FX. Cytokeratins and mucins as molecular markers of cell differentiation and neoplastic transformation in the exocrine pancreas. Zentralbl Pathol. 1994;140(3):225–35.
Wang S, You L, Dai M, Zhao Y. Mucins in pancreatic cancer: a well-established but promising family for diagnosis, prognosis and therapy. J Cell Mol Med. 2020;24(18):10279–89.
CAS PubMed PubMed Central Article Google Scholar
Nagata K, Horinouchi M, Saitou M, Higashi M, Nomoto M, Goto M, et al. Mucin expression profile in pancreatic cancer and the precursor lesions. J Hepatobiliary Pancreat Surg. 2007;14(3):243–54.
Brosens LAA, Hackeng WM, Offerhaus GJ, Hruban RH, Wood LD. Pancreatic adenocarcinoma pathology: changing ‘landscape.’ J Gastrointest Oncol. 2015;6(4):358–74.
PubMed PubMed Central Google Scholar
Waddell N, Pajic M, Patch A-M, Chang DK, Kassahn KS, Bailey P, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518(7540):495–501.
CAS PubMed PubMed Central Article Google Scholar
Sausen M, Phallen J, Adleff V, Jones S, Leary RJ, Barrett MT, et al. Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. Nat Commun. 2015;7(6):7686.
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet Lond Engl. 2011;378(9791):607–20.
Xu Z, Pothula SP, Wilson JS, Apte MV. Pancreatic cancer and its stroma: a conspiracy theory. World J Gastroenterol. 2014;20(32):11216–29.
PubMed PubMed Central Article Google Scholar
Moffitt RA, Marayati R, Flate EL, Volmar KE, Loeza SGH, Hoadley KA, et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015;47(10):1168–78.
留言 (0)